Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Shares Purchased by Raymond James & Associates

Raymond James & Associates raised its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 24.8% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 124,202 shares of the company’s stock after buying an additional 24,709 shares during the period. Raymond James & Associates owned approximately 0.13% of Acadia Healthcare worth $7,876,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. William Blair Investment Management LLC grew its stake in shares of Acadia Healthcare by 20.7% in the 2nd quarter. William Blair Investment Management LLC now owns 3,515,464 shares of the company’s stock worth $237,434,000 after purchasing an additional 604,070 shares during the last quarter. Point72 Asset Management L.P. grew its stake in shares of Acadia Healthcare by 266.0% in the 2nd quarter. Point72 Asset Management L.P. now owns 2,270,340 shares of the company’s stock worth $153,339,000 after purchasing an additional 1,650,040 shares during the last quarter. Bank of New York Mellon Corp grew its stake in shares of Acadia Healthcare by 6.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,249,369 shares of the company’s stock worth $84,382,000 after purchasing an additional 77,509 shares during the last quarter. Millennium Management LLC grew its stake in shares of Acadia Healthcare by 3,067.8% in the 2nd quarter. Millennium Management LLC now owns 1,090,313 shares of the company’s stock worth $73,640,000 after purchasing an additional 1,055,894 shares during the last quarter. Finally, Iron Triangle Partners LP grew its stake in shares of Acadia Healthcare by 14.0% in the 1st quarter. Iron Triangle Partners LP now owns 902,813 shares of the company’s stock worth $71,521,000 after purchasing an additional 110,820 shares during the last quarter.

Analyst Ratings Changes

ACHC has been the topic of several recent research reports. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, October 1st. KeyCorp started coverage on shares of Acadia Healthcare in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Barclays decreased their target price on shares of Acadia Healthcare from $83.00 to $76.00 and set an “overweight” rating for the company in a report on Monday, September 30th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Acadia Healthcare from $70.00 to $75.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 target price on shares of Acadia Healthcare in a report on Friday, September 20th. One analyst has rated the stock with a sell rating, four have given a hold rating and six have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus price target of $86.67.

Acadia Healthcare Stock Performance

ACHC stock opened at $52.08 on Thursday. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.18 and a current ratio of 1.18. The stock has a market cap of $4.83 billion, a P/E ratio of -372.00, a P/E/G ratio of 1.57 and a beta of 1.29. The firm has a 50 day simple moving average of $67.15 and a 200 day simple moving average of $68.18. Acadia Healthcare Company, Inc. has a 52 week low of $50.20 and a 52 week high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings results on Wednesday, July 31st. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.87 by $0.04. The business had revenue of $796.00 million during the quarter, compared to analysts’ expectations of $784.38 million. Acadia Healthcare had a negative net margin of 0.17% and a positive return on equity of 11.42%. The firm’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period last year, the company posted $0.92 earnings per share. Research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.51 earnings per share for the current fiscal year.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.